Deletion of DYRK1A Accelerates Osteoarthritis Progression Through Suppression of EGFR-ERK Signaling
Zhibo Liu(Beijing National Laboratory for Molecular Sciences), Mao Nie(Dalian Medical University), Xianding Sun(Dalian Medical University), Jiangping Wu(Huazhong University of Science and Technology), Chao Yu(Chongqing Medical and Pharmaceutical College), Shidong Hu(Dalian Medical University), Xin Yuan(Dalian Medical University), Zhi Li(Dalian Medical University), Ting Wang(Jilin University), Xudong Yao(Fudan University Shanghai Cancer Center), Xiaolin Quan(Dalian Medical University), Chen Shen(Dalian Medical University), Xiangwei Li(Dalian Medical University)
Cited by 7
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
A corrosion-resistant RuMoNi catalyst for efficient and long-lasting seawater oxidation and anion exchange membrane electrolyzer
|Nature Communications|2023|483
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420